DMOT4039A

Genentech, Inc. · Phase 1 active Small molecule

At a glance

Generic name	DMOT4039A
Sponsor	Genentech, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

DMOT4039A CI brief — competitive landscape report
DMOT4039A updates RSS · CI watch RSS
Genentech, Inc. portfolio CI